Danaher (NYSE:DHR) Announces Earnings Results

Key Points

• Danaher reported a quarterly earnings per share (EPS) of $1.89, exceeding analysts' expectations by $0.18 and generating revenue of $6.05 billion.
• The company has updated its fiscal year 2025 EPS guidance to a range of $7.700-$7.800, indicating positive growth expectations.
• A quarterly dividend of $0.32 per share has been declared, with a payout ratio of 27.23% and an annualized dividend yield of 0.6%.

Danaher (NYSE:DHR - Get Free Report) issued its earnings results on Tuesday. The conglomerate reported $1.89 EPS for the quarter, topping analysts' consensus estimates of $1.72 by $0.17, Zacks reports. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm earned $1.71 earnings per share. Danaher's quarterly revenue was up 4.4% compared to the same quarter last year. Danaher updated its FY 2025 guidance to 7.700-7.800 EPS.

Danaher Price Performance

NYSE DHR traded up $18.79 during trading hours on Tuesday, reaching $227.18. The company's stock had a trading volume of 4,901,240 shares, compared to its average volume of 4,222,825. The stock has a market cap of $162.67 billion, a PE ratio of 48.34, a PEG ratio of 2.98 and a beta of 0.77. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $269.24. The company's 50-day moving average is $201.76 and its two-hundred day moving average is $197.42. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's dividend payout ratio is 27.23%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DHR. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Evercore ISI lifted their price objective on shares of Danaher from $226.00 to $245.00 and gave the company an "outperform" rating in a report on Tuesday, October 7th. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Finally, Rothschild Redb cut shares of Danaher from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $245.00.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.20% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Snowden Capital Advisors LLC grew its position in Danaher by 0.6% in the second quarter. Snowden Capital Advisors LLC now owns 9,919 shares of the conglomerate's stock valued at $1,963,000 after acquiring an additional 55 shares in the last quarter. Gallagher Fiduciary Advisors LLC grew its position in Danaher by 7.5% in the second quarter. Gallagher Fiduciary Advisors LLC now owns 1,149 shares of the conglomerate's stock valued at $227,000 after acquiring an additional 80 shares in the last quarter. SkyView Investment Advisors LLC grew its position in Danaher by 1.6% in the second quarter. SkyView Investment Advisors LLC now owns 5,174 shares of the conglomerate's stock valued at $1,029,000 after acquiring an additional 83 shares in the last quarter. 44 Wealth Management LLC grew its position in Danaher by 7.8% in the second quarter. 44 Wealth Management LLC now owns 1,264 shares of the conglomerate's stock valued at $250,000 after acquiring an additional 92 shares in the last quarter. Finally, Sivia Capital Partners LLC grew its position in shares of Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock worth $397,000 after buying an additional 119 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.